AGONOX, INC.

Basic Information

4805 NE GLISAN STREET 2NC19
PORTLAND, OR, 97213-2933

Company Profile

n/a

Additional Details

Field Value
DUNS: 78369053
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Humanization of a mouse anti-OX40 monoclonal antibody to treat cancer

    Amount: $298,027.00

    DESCRIPTION (provided by applicant): Current cancer management options include chemotherapy, radiation therapy, surgery, immunotherapy, monoclonal antibody therapy and other experimental treatments. ...

    SBIR Phase I 2012 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government